Log Type Authored on Log Message Log Node Authored by
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind SEA Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind SEA Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter opened Thu, 07/30/2020 - 14:11 Opened Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Dr. Mattingly discute abordagens durante a pandemia Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Convite Lundbeck Webinar Internacional Anonymous
Newsletter opened Thu, 07/30/2020 - 13:33 Opened Anonymous
Newsletter opened Thu, 07/30/2020 - 13:25 Opened Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind newsletter Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Log Type Authored on Log Message Log Node Authored by
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind SEA Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind SEA Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter opened Thu, 07/30/2020 - 14:11 Opened Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Dr. Mattingly discute abordagens durante a pandemia Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Convite Lundbeck Webinar Internacional Anonymous
Newsletter opened Thu, 07/30/2020 - 13:33 Opened Anonymous
Newsletter opened Thu, 07/30/2020 - 13:25 Opened Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind newsletter Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous